MORF Morphic Holding Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MORF

Price (delayed)

$28.71

Market cap

$1.44B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.5

Enterprise value

$1.39B

Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. ...

Highlights
Morphic Holding's quick ratio has increased by 31% QoQ and by 19% YoY
MORF's EPS has dropped by 116% year-on-year but it is up by 2.5% since the previous quarter
MORF's debt has soared by 106% QoQ but it is down by 24% YoY
The net income has dropped by 153% year-on-year and by 6% since the previous quarter
The revenue has plunged by 100% from the previous quarter and by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://morphictx.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of MORF
Market
Shares outstanding
50.09M
Market cap
$1.44B
Enterprise value
$1.39B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.16
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$160.83M
EBITDA
-$159.71M
Free cash flow
-$128.61M
Per share
EPS
-$3.5
Free cash flow per share
-$2.57
Book value per share
$13.26
Revenue per share
$0
TBVPS
$13.65
Balance sheet
Total assets
$682.77M
Total liabilities
$19.19M
Debt
$1.47M
Equity
$663.58M
Working capital
$658.23M
Liquidity
Debt to equity
0
Current ratio
38.17
Quick ratio
37.23
Net debt/EBITDA
0.27
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-22.3%
Return on equity
-22.9%
Return on invested capital
-26.5%
Return on capital employed
-24.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MORF stock price

How has the Morphic Holding stock price performed over time
Intraday
2.65%
1 week
2.61%
1 month
-10%
1 year
-40.79%
YTD
-0.59%
QTD
-18.44%

Financial performance

How have Morphic Holding's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$193.09M
Net income
-$161.25M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 172% YoY and by 8% from the previous quarter
The net income has dropped by 153% year-on-year and by 6% since the previous quarter
The revenue has plunged by 100% from the previous quarter and by 100% YoY
The gross profit has plunged by 100% from the previous quarter and by 100% YoY

Growth

What is Morphic Holding's growth rate over time

Valuation

What is Morphic Holding stock price valuation
P/E
N/A
P/B
2.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MORF's EPS has dropped by 116% year-on-year but it is up by 2.5% since the previous quarter
The company's equity has surged by 56% YoY but it fell by 4.8% QoQ
MORF's P/B is 49% below its 5-year quarterly average of 4.2 and 6% below its last 4 quarters average of 2.3
The revenue has plunged by 100% from the previous quarter and by 100% YoY

Efficiency

How efficient is Morphic Holding business performance
The ROA has contracted by 41% YoY but it has grown by 2.6% from the previous quarter
The return on equity has declined by 37% year-on-year but it is up by 3% since the previous quarter
MORF's ROIC is down by 27% YoY but it is up by 4.3% QoQ

Dividends

What is MORF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MORF.

Financial health

How did Morphic Holding financials performed over time
The total assets has surged by 54% year-on-year but it has declined by 6% since the previous quarter
Morphic Holding's current ratio has increased by 32% from the previous quarter and by 18% YoY
MORF's debt is 100% lower than its equity
MORF's debt has soared by 106% QoQ but it is down by 24% YoY
The company's equity has surged by 56% YoY but it fell by 4.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.